These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura. Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905 [TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center. Jaime-Pérez JC; Aguilar-Calderón P; Jiménez-Castillo RA; Ramos-Dávila EM; Salazar-Cavazos L; Gómez-Almaguer D Ann Hematol; 2020 Nov; 99(11):2513-2520. PubMed ID: 32945941 [TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. Hegde UP; Wilson WH; White T; Cheson BD Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of low-dose rituximab combined with different dosage of glucocorticoids for immune thrombocytopenia]. Xing WW; Li ZY; Yan ZL; Liu KG; Li N; Cao J; Pan XY; He XP; Xu KL Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):409-12. PubMed ID: 23688751 [TBL] [Abstract][Full Text] [Related]
9. Rituximab for children with immune thrombocytopenia: a systematic review. Liang Y; Zhang L; Gao J; Hu D; Ai Y PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325 [TBL] [Abstract][Full Text] [Related]
11. Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Grace RF; Long M; Kalish LA; Neufeld EJ Pediatr Blood Cancer; 2012 Feb; 58(2):216-20. PubMed ID: 21674757 [TBL] [Abstract][Full Text] [Related]
12. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up. Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Gobert D; Bussel JB; Cunningham-Rundles C; Galicier L; Dechartres A; Berezne A; Bonnotte B; DeRevel T; Auzary C; Jaussaud R; Larroche C; LeQuellec A; Ruivard M; Seve P; Smail A; Viallard JF; Godeau B; Hermine O; Michel M Br J Haematol; 2011 Nov; 155(4):498-508. PubMed ID: 21981575 [TBL] [Abstract][Full Text] [Related]
14. The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP). Basciano PA; Bussel J; Hafeez Z; Christos PJ; Giannakakou P Br J Haematol; 2013 Jan; 160(2):237-43. PubMed ID: 23157319 [TBL] [Abstract][Full Text] [Related]
15. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Lu KH; George JN; Vesely SK; Terrell DR Am J Med Sci; 2014 Mar; 347(3):190-4. PubMed ID: 23462246 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related]
17. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Patel VL; Mahévas M; Lee SY; Stasi R; Cunningham-Rundles S; Godeau B; Kanter J; Neufeld E; Taube T; Ramenghi U; Shenoy S; Ward MJ; Mihatov N; Patel VL; Bierling P; Lesser M; Cooper N; Bussel JB Blood; 2012 Jun; 119(25):5989-95. PubMed ID: 22566601 [TBL] [Abstract][Full Text] [Related]
18. Current therapies in primary immune thrombocytopenia. Pels SG Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265 [TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity. Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618 [TBL] [Abstract][Full Text] [Related]